Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $18.7950 (-0.66%) ($18.7950 - $18.7950) on Thu. Jan. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.25% (three month average) | RSI | 25 | Latest Price | $18.7950(-0.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.125% in a week (0% probabilities). VIXM(-34%) VXX(-27%) UNG(-10%) UUP(-9%) TLT(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.125% (StdDev 4.25%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $20.58 | 5 Day Moving Average | $19.57(-3.96%) | 10 Day Moving Average | $19.51(-3.66%) | 20 Day Moving Average | $20.58(-8.67%) | To recent high | -28.6% | To recent low | 48.2% | Market Cap | $1.397b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |